Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Advanced Heart Failure and Transplant
Is it reasonable to start de-escalating GDMT for patients with recovered LVEF following PCI for anterior STEMI, and if so, what class of medication would you consider stopping first?
Related Questions
What are your preferred echocardiographic parameters and goals for weaning RVAD support?
What aspects of HF management do you think hospitalists should prioritize before discharge in order to optimize HF admission care if there are limited resources available for specialized HF care, both inpatient and outpatient?
What are the best techniques to reduce POCUS artifact and increase the diagnostic accuracy of lung ultrasound?
Is there a role for measuring plasma aldosterone to guide the treatment of heart failure in specific populations?
Given findings from the LIFE trial, are there any benefits in using Entresto over valsartan alone in HFrEF patients?
What is your approach to treating patients with decompensated heart failure when their hypervolemia is refractory to oral furosemide?
Would you perform a diagnostic paracentesis for first-time ascites in a patient with established CHF or pulmonary hypertension, but without apparent liver or other intra-abdominal disease?
How do you think about using contraction alkalosis as a mark of achieving goal diuresis?
For patients with HFrEFand consitent SBP readings in the 90s with baseline CKD and borderline elevated K within the high 5 range, how do you prioritize which medications to uptitrate for GDMT when BP, labs, renal function provide limitations?
What is your approach when a patient has concomitant acute decompensated heart failure and rapid atrial fibrillation?
